Get In Touch
541 Melville Ave, Palo Alto, CA 94301,
Ph: +1.831.705.5448
Work Inquiries
Ph: +1.831.306.6725

The Medicametrix opportunity

MedicaMetrix has opened our investment offering to everyone – because we believe that everyone should have the opportunity to help change the future of prostate disease management. With a minimum investment of $750 you are making an investment in:

$3.32 - $7.65 BILLION Market Size

The $3.32 – $7.65 BILLION dollar cancer diagnostic market usually reserved for institutional and large investors.  Your investment gives you a piece of the Medical Technology industry.

The Future of Prostate Disease Diagnosis

ProstaMetrix is a portable, physician’s office medical tech device that turns a digital rectal exam into a next generation cancer screening tool. The ProstaMetrix device makes it possible to treat multiple forms of prostate disorder and diseases in a low-cost, point-of-care and real-time procedure

2nd leading cause of cancer death in men in the US

One in eight men will be diagnosed with prostate cancer, over 33,330 will die in the US alone

The future of Prostate Disease Management. Our goal is provide the tools to diagnose Prostate Cancer and Prostate Disease EARLIER – leading to a better chance of treatment.  Your investment helps us get there.

What's the next step

If you would like more information on MedicaMetrix, click here to have a member of our team reach out to you.

Want to invest?  Click here to start filling out our investment form.  You will have multiple opportunities to confirm your investment level.

* View our Offering Circular HERE